Copper levels needed to rise by 50% to show an association with disease severity, and this link emerged only after accounting for C-reactive protein levels—suggesting that copper may contribute to COVID-19 severity through its pro-inflammatory and pro-oxidant effects (Al-Saleh et al., 2022). The gene discussed is CRP; the disease is COVID-19.